Literature DB >> 14642194

Cardiovascular Complications in Patients with HIV Infection.

Karolina M. Zareba1, Steven E. Lipshultz.   

Abstract

As advances in early diagnosis and aggressive therapy, as well as better supportive care, become available to a larger number of patients with HIV infection, survival is being prolonged, and more patients are experiencing cardiac abnormalities. The most common cardiac manifestations of HIV disease are dilated cardiomyopathy, myocarditis, pericardial effusion, endocarditis, pulmonary hypertension, HIV-associated malignant neoplasms, and drug-related cardiotoxicity. The introduction of highly active antiretroviral therapy (HAART) regimens has substantially modified the course of HIV disease by lengthening survival and improving quality of life of HIV-infected patients. However, early data have raised concerns about HAART being associated with an increase in peripheral and coronary arterial disease. This review discusses the principal HIV-associated cardiovascular manifestations and emphasizes new knowledge about their prevalence, pathogenesis, and treatment.

Entities:  

Year:  2003        PMID: 14642194     DOI: 10.1007/s11908-003-0096-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  52 in total

1.  The changing face of pediatric HIV-1 infection.

Authors:  J L Sullivan; K Luzuriaga
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

Review 2.  Effect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapy.

Authors:  Daniele Scevola; Angela Di Matteo; Paolo Lanzarini; Filippo Uberti; Silvia Scevola; Verginia Bernini; Greta Spoladore; Angela Faga
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

Review 3.  Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Authors:  Morris Schambelan; Constance A Benson; Andrew Carr; Judith S Currier; Michael P Dubé; John G Gerber; Steven K Grinspoon; Carl Grunfeld; Donald P Kotler; Kathleen Mulligan; William G Powderly; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2002-11-01       Impact factor: 3.731

Review 4.  Clinical cardiac manifestations of HIV infection: a review of current literature.

Authors:  William W Chu; James M Sosman; James H Stein
Journal:  WMJ       Date:  2002

5.  Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; G Sopko; S D Colan
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

6.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 7.  Epidemiology of cardiovascular involvement in HIV disease and AIDS.

Authors:  S D Fisher; S E Lipshultz
Journal:  Ann N Y Acad Sci       Date:  2001-11       Impact factor: 5.691

8.  Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study.

Authors:  Steven E Lipshultz; Kirk A Easley; E John Orav; Samuel Kaplan; Thomas J Starc; J Timothy Bricker; Wyman W Lai; Douglas S Moodie; George Sopko; Mark D Schluchter; Steven D Colan
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

Review 9.  Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy.

Authors:  Tracie L Miller
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

Review 10.  Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes.

Authors:  Stacy D Fisher; Neil E Bowles; Jeffrey A Towbin; Steven E Lipshultz
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

View more
  4 in total

Review 1.  Myocardial disease in human immunodeficiency virus (HIV) infection: a review.

Authors:  Mahmoud Umar Sani
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors.

Authors:  Lakshmanan Annamalai; Susan V Westmoreland; Heber G Domingues; Dennis G Walsh; R Gilberto Gonzalez; Shawn P O'Neil
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

3.  Cardiovascular manifestations of people living with HIV/AIDS: Report from a hot spot in eastern India.

Authors:  Trinath Kumar Mishra; Sura Kishor Mishra; Subhasish Singh
Journal:  Indian Heart J       Date:  2019-09-09

Review 4.  Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.

Authors:  Steven E Lipshultz; Tracie L Miller; James D Wilkinson; Gwendolyn B Scott; Gabriel Somarriba; Thomas R Cochran; Stacy D Fisher
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.